Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medi-Cal Incentives to Quit Smoking
NCT01502306Phase 3Completed
- Sponsor
- University of California, San Diego
- Start
- Jun 2012
- Primary completion
- Feb 2014
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (3 arms), sponsored by University of California, San Diego. Primary endpoint: 30-day Abstinence at 7 months. Started Jun 2012; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01502306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502306.